tirzepatide south africa Exciting News! Aspen Pharmaceuticals has officially launched Mounjaro ( Tirzepatide) in Africa! Mounjaro is the latest addition to the GLP family to make its way to SA. To clarify and avoid any Public health threat as South

Semaglutide improves both NASH and tumor burden in GAN DIO-NASH-HCC mice, highlighting the suitability of this preclinical model for profiling novel drug therapies targeting NASH-HCC

Compared with the lowest quartile, hazard ratio (95% CI) of the highest quartile was 2.47 (1.48-4.14) for FIX, 1.37 (0.85-2.20) for FVIII, 1.11 (0.76-1.63) for FXI, 0.98 (0.65-1.48) for fibrinogen, 1.56 (1.07-2.28) for ETP, 1.84 (1.23-2.74) for peak, 1.59 (1.08-2.33) for velocity, 0.92 (0.62-1.38) for lag time, and 1.21 (0.86-1.70) for time-to-peak

The study found no higher odds for thyroid cancer among folks taking GLP-1 analogues compared to those on DPP4 inhibitors

NovoCare offers the pill at $149 per month for the starter dose through at least August 2026, making it the cheapest FDA-approved GLP-1 option for cash-pay patients